openPR Logo
Press release

How Epigenomics Market Will Dominate In Coming Years? Key Players: Thermo Fisher Scientific, Illumina, Novartis, Merck Life Science, Agilent Technologies, Merck KGaA, Darmstadt, Merck Life Science, Germany, Merck Millipore, Epigenomics AG, Zymo Research C

07-02-2019 02:16 PM CET | Energy & Environment

Press release from: Fortune Business Insights Pvt. Ltd.

How Epigenomics Market Will Dominate In Coming Years? Key

Fortune Business Insights foresees the pharmaceutical segment to dominate the global epigenomics market on account of the increasing prevalence of chronic diseases such as cancer. According to the World Health Organization (WHO), by the end of 2025, the number of cancer patients will reach 21,471,996.

Sample PDF Brochure https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/epigenomics-market-100193

The increasing prevalence of chronic diseases such as cancer is helping the global epigenomics market to emerge with remarkable market figures, finds Fortune Business Insights in their new study. The study is titled, “Epigenomics Market: Global Market Analysis, Insights, and Forecasts, 2019 – 2026.” An important factor propelling this market is the rise in number of chronic diseases and their needful treatment worldwide.

Increasing Funding from Government to Help Market Gain Momentum

A major factor boosting the Global Epigenomics Market is the rising number of cancer cases in the world, followed by rising investment in research projects in order to develop novel therapeutics for such chronic diseases. The rise in number of funds raised by the government for such research and development will help the market witness immense growth.

Rise in geriatric population and their vulnerability towards various health issues will also create lucrative growth opportunities for the market. This, coupled with growth in market for personalized medicines, is also helping the market grow remarkably. The increasing importance for epigenetic technology will help the market gain potential in the future.

However, a major cause of concern for players operating in the epigenomics market is the inefficiency in validation and identification of biomarkers. This, coupled with the presence of complex regulatory framework for epigenomics may hamper the growth of the market in the long run. Again, the lack of skilled professionals in this field may also cause hindrance to the market in the long run.

Company profiled in this report based on Business overview, Financial data, Product landscape, Strategic outlook & SWOT analysis: Thermo Fisher Scientific, Illumina, Novartis, Merck Life Science, Agilent Technologies, Merck KGaA, Darmstadt, Merck Life Science, Germany, Merck Millipore, Epigenomics AG, Zymo Research Corp, Bayer Technology Services

Get Customized at https://www.fortunebusinessinsights.com/enquiry/customization/epigenomics-market-100193

SEGMENTATION

By Product Type

· Reagents
· Kits
· Enzymes
· Others

By Technology

· DNA Methylation
· Histone Methylation
· Histone Acetylation
· MicroRNA Modification
· Large Non-coding RNA
· Chromatin Structures
· Others

By Application

· Pharmaceutical
· Diagnostics

By Geography

· North America (USA and Canada)
· Europe (UK, Germany, France, Italy, Spain, Scandinavia and Rest of Europe)
· Asia Pacific (Japan, China, India, Australia, Southeast Asia and Rest of Asia Pacific)
· Latin America (Brazil, Mexico and Rest of Latin America)
· Middle East & Africa (South Africa, GCC and Rest of Middle East & Africa)

Browse Full Report at https://www.fortunebusinessinsights.com/industry-reports/epigenomics-market-100193

About Us:
Fortune Business Insights offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.

Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.

At Fortune Business Insights we aim at highlighting the most lucrative growth opportunities for our clients. We therefore offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.

Contact us:

Fortune Business Insights Pvt. Ltd.
308, Supreme Headquarters,
Survey No. 36, Baner,
Pune-Bangalore Highway,
Pune - 411045, Maharashtra, India.

Phone:

US :+1 424 253 0390
UK : +44 2071 939123
APAC : +91 744 740 1245
Email: sales@fortunebusinessinsights.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release How Epigenomics Market Will Dominate In Coming Years? Key Players: Thermo Fisher Scientific, Illumina, Novartis, Merck Life Science, Agilent Technologies, Merck KGaA, Darmstadt, Merck Life Science, Germany, Merck Millipore, Epigenomics AG, Zymo Research C here

News-ID: 1794128 • Views:

More Releases from Fortune Business Insights Pvt. Ltd.

Luxury Goods Market Size Report, Trends, Overview, Outlook & Future Growth By 2030
Luxury Goods Market Size Report, Trends, Overview, Outlook & Future Growth By 20 …
The global luxury goods market size was valued at USD 272.74 billion in 2022. The market is anticipated to grow from USD 284.00 billion in 2023 to USD 392.40 billion by 2030, exhibiting a CAGR of 4.7% during the forecast period. Luxury products signify the status symbol of an individual. Businesses focus on high-income populations with visually appealing designs and technology-integrated products. For instance, NFC-installed chips in jewelry; a product called
With 17.2% CAGR, Smart Glass market Market to Hit USD 15,788.0 Million by 2022-2027 | Key Companies Profiled: BSG Glass, NSG Groupe, Schott AG
With 17.2% CAGR, Smart Glass market Market to Hit USD 15,788.0 Million by 2022-2 …
The global smart glass market size is anticipated to reach USD 15,788.0 million by 2027, owing to the rise in the use of smart glass for different applications such as aerospace, marine, architectural, and automotive. Smart glass or switchable glass is glazing or a glass with altered transmission properties as and when heat, light, or voltage is applied. They are capable of changing their appearance from opaque to translucent to transparent
Non-alcoholic Beverages Market Segmentation& Analysis, Industry Growth Forecast 2020-2027
Non-alcoholic Beverages Market Segmentation& Analysis, Industry Growth Forecast …
According to Fortune Business Insights ™, the global non-alcoholic beverages market size is anticipated to rise significantly on account of the current trend of health and fitness and the rising inclination towards healthy beverages. The value of this market was USD 919.13 billion in 2019 and is expected to rise at a CAGR of 8.20% between 2020 to 2027 to reach USD 1,257.77 billion by the end of 2027. List of
Intravenous Iron Drugs Market 2022: Global Technology, Segmentation, Growth, Development, Trends and Forecasts to 2027
Intravenous Iron Drugs Market 2022: Global Technology, Segmentation, Growth, Dev …
Global Intravenous Iron Drugs Market Size research report 2022 offers an in-depth assessment of revenue growth, market definition, segmentation, industry potential, influential trends for understanding the future outlook and current prospects for the market. The demand for refractive surgeries is anticipated to increase, attributed to the rise in the aging population and excessive use of digital devices, which has increased the screen time of the world population due to the

All 5 Releases


More Releases for Epigenomics

Global Epigenomics Market: Regional Analysis and Technological Analysis till 203 …
The Global Epigenomics Market accounted for US$ 1.2 billion in 2020 and is estimated to be valued at US$ 3.9 Billion by 2030 and is anticipated to register a CAGR of 13.5%. According to the National Human Genome Research Institute, the epigenome is made up of chemical compounds and proteins that can attach to DNA and direct such actions as turning genes on or off, controlling the production of proteins
Epigenomics Market Size, Growth, Share Statistics 2020-2026 | Key Players: Abbot …
Epigenomicss Market Research Report 2020 is a valuable supply of insightful information for business strategists with Top Countries Data. Furthermore, market size, the revenue shares of each segment and its sub-segments, as well as forecast figures are also covered in this report. The report study provides key statistics on the market status of the Epigenomics manufacturers and is a valuable source of guidance and direction for companies and individuals interested
COVID-19 Impact On Epigenomics Market | Top Key Players: Abbott, Boehringer Inge …
Epigenomics Market 2020 - 2026 includes systematic information regarding to Epigenomics Industry. Report provides Epigenomics Industry and provides statistics and information on market dynamics, growth factors, key challenges, major drivers and restraints, opportunities and forecast 2026. Top Key Players: Abbott, Boehringer Ingelheim, Agilent Technologies, Bayer, Thermo Fisher Scientific, Epizyme, Abcam, Zymo Research Corporation, Merck, Epigenomics, Illumina Inc., Novartis. To know How COVID-19 Pandemic Will Impact This Market/Industry -Request a sample copy of
Personalized Medicine and Epigenomics Market Size, Share, Development by 2024
Global Info Research offers a latest published report on Personalized Medicine and Epigenomics Market Analysis and Forecast 2019-2025 delivering key insights and providing a competitive advantage to clients through a detailed report. The report contains 124 pages which highly exhibit on current market analysis scenario, upcoming as well as future opportunities, revenue growth, pricing and profitability. Click to view the full report TOC, figure and tables: https://www.globalinforesearch.com/global-personalized-medicine-and-epigenomics-market_p104101.html   Epigenomics is the study of the
Personalized Medicine and Epigenomics Market Should Reach To $12.1 billion till …
"The Latest Research Report Personalized Medicine and Epigenomics: Technologies and Global Markets provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz" The global epigenomic market reached nearly $4 billion in 2014 and $4.7 billion in 2015. The market should reach nearly $12.1 billion in 2020, demonstrating a compound annual growth rate (CAGR) of 20.6% from 2015 to 2020. North America dominated the global epigenomic
Sample Preparation in Genomics, Proteomics, and Epigenomics Market - Global Indu …
Sample preparation is one of the most crucial steps in analysis of any particular biological substance or chemical. Analytical procedure usually consists of steps such as sampling, sample preservation, sample preparation, separation detection, and data analysis. After sampling and sample preservation, the next vital step is usually the sample preparation, which consumes over 70% of the analysis time. Since sample preparation is the most time consuming step in any analysis and